Universidade Federal de Minas Gerais   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Belo Horizonte Brazil (1927)

Organization Overview

First Clinical Trial
2002
NCT00038480
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Escola de Medicine, Universidade Federal de Minas Gerais | Medical School of Universidade Federal de Minas Gerais | UFMG

Active Ingredients

Drugs in Phase 4 Trials (1)

saccharomyces boulardii (1 trial)

Drugs in Phase 3 Trials (2)

chlorhexidine (hibitane) (1 trial)

propolis (1 trial)

Drugs in Phase 2 Trials (1)

amino acids (Freamine) (1 trial)

Drugs in Phase 1 Trials (2)

lopinavir (Kaletra) (1 trial)

ritonavir (Norvir) (1 trial)

Drugs in Other Trials (1)

conjugated equine estrogens (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 4)

Gingivitis (Phase 3)

HIV Infections (Phase 1)

Hypersensitivity (Phase 2)

Inflammation (Phase 3)

Milk Hypersensitivity (Phase 2)

Periodontitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7